Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
JCSE01 - Joint IASLC-CSCO-CAALC Session
- 07:00 - 11:15
- 9/07/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Joint IASLC-CSCO-CAALC Session
- Track:
- Moderators:Chunxue Bai, Tony Mok, Yi-Long Wu, Qing Zhou, Nan Wu
-
+
JCSE01.23 - Specific TP53 Mutation Subtypes as Biomarker for Response to PD-1/L1 Blockade Immunotherapy in NSCLC
10:45 - 10:45 | Presenter: Hao Sun | Author(s): Si-yang Liu, Jia Ying Zhou, Meimei Zheng, Jiao Jiao Huan, Yan Fang Guan, Rui Gao, Xin Yi, Yi-Long Wu
- Abstract
Loading...
-
+
EP1.01 - Advanced NSCLC
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
EP1.01-103 - Long-Term Response to Second-Line Afatinib for the Treatment of Advanced Lung Squamous Cell Carcinoma
08:00 - 08:00 | Presenter: Ye Guo | Author(s): Kewei Ma, Xu Wang, Mengyao Sun, Yinghui Xu, Chao Sun, Shi Qiu
- Abstract
Loading... -
+
EP1.01-106 - A Special Case of Synchronous Multiple Primary Lung Cancer with Mediastinal Lymph Node Metastases of Unknown Primary Origin
08:00 - 08:00 | Presenter: Kewei Ma | Author(s): Mengyao Sun, Yinghui Xu, Xu Wang, Chao Sun, Ye Guo, Shi Qiu
- Abstract
Loading... -
+
EP1.01-59 - The Effectiveness of Osimertinib in a NSCLC Patient with Complex Uncommon EGFR Mutations of G719X and S768I: A Case Report
08:00 - 08:00 | Presenter: Kewei Ma | Author(s): Xu Wang, Yangyang Cai, Yinghui Xu, Ye Guo, Chao Sun
- Abstract
Loading...
-
+
EP1.04 - Immuno-oncology
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
EP1.04-36 - Aggravation of Depigmentation for a NSCLC Patient with Pre-Existing Vitiligo Using Immune Check Point (PD-1) Inhibitor: A Case Report
08:00 - 08:00 | Presenter: Kewei Ma | Author(s): Yangyang Cai, Yinghui Xu, Xu Wang, Chao Sun, Ye Guo
- Abstract
Loading...
-
+
EP1.14 - Targeted Therapy
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
EP1.14-13 - EGFR Mutation in Lung Adenocarcinoma: Real World Study from a Single Institute
08:00 - 08:00 | Presenter: Gebang Wang | Author(s): Chenlei Zhang, Wenyuan Shang, JINGHAN Li, HAICHAO Sun, Zhanwu Yu, Hong-Xu Liu
- Abstract
Loading... -
+
EP1.14-48 - Efficacy and Safety of Afatinib Plus Apatinib Combination Therapy for a Lung Adenocarcinoma Patient with Her-2 V659D Mutation
08:00 - 08:00 | Presenter: Kewei Ma | Author(s): Chao Sun, Yinghui Xu, Xu Wang, Ye Guo
- Abstract
Loading... -
+
EP1.14-50 - The Effectiveness of the Combined Therapy of Osimertinib and Vemurafenib in a Patient with Coexistance of EGFR and BRAF Mutation
08:00 - 08:00 | Presenter: Kewei Ma | Author(s): Mengyao Sun, Xu Wang, Yinghui Xu, Chao Sun, Ye Guo, Shi Qiu
- Abstract
Loading...
-
+
P1.12 - Small Cell Lung Cancer/NET
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
-
+
P1.12-14 - Phase II Trial of Apatinib Plus Chemotherapy for Second-Line and Above Treatment of Advanced SCLC: Focus on Efficacy and Safety
09:45 - 09:45 | Presenter: Kewei Ma | Author(s): Yinghui Xu, Xu Wang, Yangyang Cai, Chao Sun, Ye Guo, Shi Qiu
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-13 - EGFR Amplification Mediates Resistance to Third-Generation EGFR TKIs and in Vitro Validation of Combination Strategies to Overcome Resistance
09:45 - 09:45 | Presenter: Yi-Chen Zhang | Author(s): Qing Zhou, Zhihong Chen, Xu-Chao Zhang, Jian Su, Hao Sun, Si-yang Liu, Yi-Long Wu
- Abstract
Loading... -
+
P1.14-31 - Lack of Association Between BIM Deletion Polymorphism and Clinical Efficacy of EGFR-TKIs in NSCLC Based on NGS
09:45 - 09:45 | Presenter: Si-Yang Liu | Author(s): Wen-Feng Li, Hao Sun, Yi-Chen Zhang, Jia-Ying Zhou, Jin-Ji Yang, Yi-Long Wu
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-88 - Molecular Alterations in Cerebrospinal Fluid Predict Clinical Outcomes of Central Nervous System Metastases in Lung Cancer
10:15 - 10:15 | Presenter: Meimei Zheng | Author(s): Yangsi Li, Benyuan Jiang, Haiyan Tu, Junyi Ye, Jin-Ji Yang, Xu-Chao Zhang, Shannon Chuai, Hao Sun, Qing Zhou, Wen-Zhao Zhong, Yi-Long Wu
- Abstract
Loading...
-
+
P2.03 - Biology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Biology
-
+
P2.03-46 - PI3K/AKT Signal Pathway Regulates Malignant Transformation of MPLC with EGFR-Sensitive Mutation
10:15 - 10:15 | Presenter: Kewei Ma | Author(s): Yangyang Cai, Xu Wang, Yinghui Xu, Ye Guo, Chao Sun, Shi Qiu
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P2.14-06 - The Study of Rac3 Molecular Mechanism Through ERK Signaling Pathway in Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Hong-Xu Liu | Author(s): JINGHAN Li, HAICHAO Sun, Gebang Wang, Chenlei Zhang, YI Zhang, Guan Wang, PENG Zu
- Abstract
Loading...
